Chemistry: molecular biology and microbiology – Vector – per se
Reexamination Certificate
2007-08-14
2007-08-14
Priebe, Scott D. (Department: 1633)
Chemistry: molecular biology and microbiology
Vector, per se
C424S093200, C435S091400, C435S325000, C514S04400A
Reexamination Certificate
active
10402954
ABSTRACT:
The invention relates to an adenovirus fiber modified by the mutation of one or more residues. The residues are directed towards the natural cell receptor in the three-dimensional structure of said adenovirus. The invention further relates to a DNA fragment, and expression vector, and a cell line expressing said fiber, and also concerns an adenovirus, the process for producing this type of adenovirus, and an infectable host cell, as well as their therapeutic application and a corresponding pharmaceutical composition.
REFERENCES:
patent: 5543328 (1996-08-01), McClelland et al.
patent: 5846782 (1998-12-01), Wickham et al.
patent: 2004/0038205 (2004-02-01), Van Raaij et al.
patent: 94 14470 (1996-06-01), None
patent: WO94/17832 (1994-08-01), None
patent: WO94/28152 (1994-12-01), None
patent: WO95/05201 (1995-02-01), None
patent: WO95/16048 (1995-06-01), None
patent: WO95/26412 (1995-10-01), None
patent: WO96/13597 (1996-05-01), None
patent: WO96/26281 (1996-08-01), None
Krasnykh et al., “Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism,” J. Virol., 70(10): 6839-6846, Oct. 1996.
Remy et al. 1994, Bioconjugate Chemistry 5, 647-654, American Chemical Society, Washington, D.C., U.S.A.
Roelvink et al, 1996 J. Virol. 70, 7614-7621, American Society for Microbiology, Washington, D.C., U.S.A.
Gooding and Wold, 1990, Critical Reviews Immunology 10, 53-71, Begell House, New York, NY, U.S.A.
Ensinger et al, 1972, J. Virol. 10. 328-339, American Society for Microbiology, Washington, D.C., U.S.A.
Ido et al, 199b, Cancer Res. 55, 3105-3109, American Association for Cancer Research, Baltimore, MD, U.S.A.
Lee et al, 1996, J. Biol. Chem. 271-4561-4568, American Society for Biochemistry and Molecular Biology, Bethesda, Maryland, U.S.A.
Morishita et al, 1995, J. Biol. Chem. 270, 27948 27953, American Society for Biochemistry and Molecular Biology, Bethesda, Maryland, U.S.A.
Graham and Prevec, 1991, Methods in Molecular Biology, vol. 7, p. 109-128: Ed. E.J. Murray, The Human Press, Inc.
Hubacek and Glover, 1970, J. Mol. Biol. 50, 111-127, Academic Press, San Diego, California, U.S.A.
Hanahan, 1983, J. Mol. Biol. 166, 557-580, Academic Press, San Diego, California, U.S.A.
Wells et al, 1990, Science 247: 962-964, American Association for the Advancement of Science with the assistance of Stanford University's Highwire Press, Stanford, California, U.S.A.
Schneider et al. 1986, Proc. Natl. Acad. Sci. USA 83, 333-336, National Academy of Sciences, Washington, D.C.
Quillet et al, 1988, J. Immunol. 141, 17-20, The American Association of Immunologists. Bethesda, MD, U.S.A.
Kieny et al, 1983, Gene 26. 91-99, Elsevier Science, Oxford, U.K.
Chartier et al. 1996, J. Virol. 70, 4805-4810, American Society for Microbiology, Washington, D.C.
Zachary et al, 1985, Proc. Natl. Acad. Sci. USA 82, 7616-7620, National Academy of Sciences, Washington, D.C.
Battey et al, 1991, Proc. Natl. Acad. Sci. USA 88, 395-399, National Academy of Sciences, Washington, D.C.
Corjay et al, 1991, J. Biol. Chem 266. 18771-18779, American Society for Biochemistry and Molecular Biology, Bethesda, MD, U.S.A.
Stratford-Perricaudet et al, 1992, J. Clin. Invest. 90, 626-630, American Society for Clinical Investigation, Thorofare, NJ. U.S.A.
Boshat et al, 1985, Cell 41, 521-530, Cell Press, Cambridge, Massachusetts, U.S.A.
J. Gall et al., Journal of Virology, 70(4):2116-2123 (1996), American Society for Microbiology, Washington, D.C.
A. McClelland et al., Journal of Cellular Biochemistry—Supplement, p. 411 (1995), Wiley-Liss, New York, NY, U.S.A.
PCR Protocols—A Guide to Methods and Application, 1990, edited by Innis, Gelfand, Sninsky & White, Academic Press, Inc., pp. v-xi & Title page only.
Bramson et al, 1995, Curr. Op. Biotech. 6, 590-595, Current Biology, London, U.K.
Graham et al. 1977, J. Gen. Virol. 36, 59-72, Society for General Microbiology, London, U.K.
Philipson et al, 1968, J. Virol. 2, 1064-1075, American Society for Microbiology, Washington, D.C., U.S.A.
Defer et al, 1990, J. Virol. 64, 3662-3673, American Society for Microbiology, Washington, D.C., U.S.A.
Mathias et al, 1994, J. Virol. 68, 6811-6814, American Society for Microbiology, Washington, D.C., U.S.A.
Chroboczek et al, 1995, Current Top. Microbiol. Immunol. 199, 165-200, Berlin, New York, New York, U.S.A.
Hong and Engler, 1996, J. Virol. 70, 7071-7078. American Society for Microbiology, Washington, D.C., U.S.A.
Novelli and Boulanger. 1991, J. Biol. Chem. 266, 9299-9303, American Society of Biochemistry and Molecular Biology, Bethesda, Maryland U.S.A.
Novelli and Boulanger, 1991, Virology 185, 365-376, Academic Press, New York, New York, U.S.A.
Henry et al, 1994, J. Virol. 68, 5239-5246, American Society for Microbiology, Washington, D.C., U.S.A.
Louis et al, 1994, J. Virol. 68, 4104 4106, American Society for Microbiology, Washington, D.C., U.S.A.
Bergelson et al. 1997, Science 275, 1320-1323, American Association for the Advancement of Science with the assistance of Stanford University's Highwire Press, Stanford, California, U.S.A.
Herisse et al, 1981, Nucleic Acid Res. 9, 4023-4042, IRL Press Limited, Oxford, England.
Chronboczek and Jacrot. 1987, Virology 161, 549-554, Academic Press, New York, New York.
Xia et al, 1994, Structure 2, 1259-1270, Current Biology, London, U.K.
Stryer, Biochemistry, 2ndedition, Chapter 2, pp. 11-39, Ed. Freeman and Co., San Francisco.
Fawell et al, 1994, Proc. Natl. Acad. Sci. USA 91. 664-668, National Academy of Sciences, Washington, D.C., U.S.A.
Michael et al, 1995 , Gene Therapy 2, 660 668, Nature Publishing Group, London, U.K.
Felgner et al, 1989, Proc. West. Pharmacol. Soc. 32, 115-121, Western Pharmacological Society. Seattle, WA. U.S.A.
Hodgson and Solarman, 1996, Nature Biotechnology 14, 339-342, Nature Publishing Group, Hampshire, U.K.
Boulanger Pierre
Legrand Valérie
Mehtali Majid
Buchanan & Ingersoll & Rooney PC
Priebe Scott D.
Transgene
LandOfFree
Modified adenoviral fiber and target adenoviruses does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Modified adenoviral fiber and target adenoviruses, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modified adenoviral fiber and target adenoviruses will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3851679